We are constantly seeking new opportunities to commercialise our world-class research, usually in the form of licensing patents or copyright, or forming spinout companies – and we offer on-site incubation facilities.
Here are some examples of our knowledge transfer activity.
Parity Group Plc and Royal Holloway are working together to implement an innovative social media search tool.
Developed by researchers needing to recognise links and associations within massive data sets, the new software, GroupSeer™ offers the potential to better understand the behaviour of online users based on insights into human social behaviour.
The patented algorithm uses a powerful and unique combination of social graph and language techniques.
SporeGen is a spinout from Royal Holloway focusing on Bacillus and its commercial applications in novel vaccine technologies, probiotics, drug delivery and targeting and related sectors.
Founded in 2012 by Professor Simon Cutting, SporeGen is developing products such as heat-stable vaccines that can be delivered needle-free either orally or nasally.
The company is currently developing two lead vaccine candidates and has partners in Europe, India and Vietnam.
MVE has worked with the Department of Earth Sciences to develop software which predicts the distribution and capacity of oil within single wells.
As a result of the collaboration, MVE has an exclusive licence to use the software within their organisation and to re-sell to other users.